Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 14.8414.4512.358.4110.14

What is the latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS is 14.84 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202514.84
Mar202414.45
Mar202312.35
Mar20228.41
Mar202110.14

How is EV/Core EBITDA of SMS PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 14.84
2.70
Mar2024 14.45
17.00
Mar2023 12.35
46.85
Mar2022 8.41
-17.06
Mar2021 10.14 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹3,749.9 Cr -4.5% -8.6% 62.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.4% 10.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 0.7% 9.5% 16.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr -2.5% 6% 36.2% Stock Analytics
CIPLA ₹115,641.0 Cr 9.7% 16.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 4.5% 9.7% 9% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-4.5%

-8.6%

62.8%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses